Leukemia: Clinical Trials

89 trials for Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

89 completed. 89 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 489Completed 89

Follow Leukemia: new trials by email Literature Review of Leukemia trials Research Report on Leukemia

Trials (filtered) newest first · largest first

All 89 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation
Asciminib - Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Phase 4CompletedNovartis Pharmaceuticals852024-11-282026-06-08
Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia
Comparison short vs extended EBAT treatment group - Neutropenia, Febrile
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven4502024-02-262026-10-23
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
Bridion 200 MG in 2 ML Injection, Pyridostigmine Bromide 5 MG/ML - Emergence Delirium, Strabismus
Phase 4CompletedKonkuk University Medical Center762023-12-012026-07-15
A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
inotuzumab ozogamicin - Acute Lymphoblastic Leukemia
Phase 4CompletedPfizer442023-02-242025-12-03
Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy
Venetoclax, Azacitidine, Decitabine - Acute Myeloid Leukemia
Phase 4CompletedBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh242022-06-012026-08-21
Ropeginterferon for Treatment Free Remission
Ropeginterferon - CML (Chronic Myelogenous Leukemia)
Phase 4CompletedDong-Wook Kim652021-11-302025-08-22
Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma
Acalabrutinib capsule - Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
Phase 4CompletedAstraZeneca1032021-07-142024-11-22
Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy
Nalbuphine Injection, Ketamine, Saline - Pediatric ALL, Pediatric Anesthesia
Phase 4CompletedAin Shams University902021-03-252022-01-04
Regional Anesthesia for Totally Awake Upper Limb Surgery in PEDiatric Population
local anaesthetic injection - Surgery, Anesthesia, Local
Phase 4CompletedGCS Ramsay Santé pour l'Enseignement et la Recherche1002020-10-142026-07-16
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
inotuzumab ozogamicin-dose level 2, Inotuzumab ozogamicin-dose level 1 - Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma
Phase 4CompletedPfizer1022019-07-012023-11-22
A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion
Ibrutinib 420 mg, Ibrutinib 560 mg - Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell
Phase 4CompletedJohnson & Johnson Private Limited752019-06-262025-05-25
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
Ceftazidime Injection, Cefepime Injection - Neutropenia, Febrile, Leukemia
Phase 4CompletedUniversitas Indonesia722019-03-012019-12-06
Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO
Bivalirudin, Unfractionated heparin - Extracorporeal Membrane Oxygenation Complication, Pediatric ALL
Phase 4CompletedUniversity of Texas Southwestern Medical Center302018-03-252023-01-31
MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
MP Diagnostics HTLV Blot 2.4 - HTLV-I Infections, HTLV-II Infections
Phase 4CompletedMP Biomedicals, LLC1502018-01-152018-09-13
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
Vitamin D3, Standard Vitamin D3 Supplementation - Vitamin D Deficiency, Stem Cell Transplant Complications
Phase 4CompletedPhoenix Children's Hospital492017-11-012020-11-17
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
budesonide, beclomethasone - Asthma, Pediatric ALL
Phase 4CompletedNew York City Health and Hospitals Corporation432017-09-102019-07-18
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
Fludarabine, Cytarabine - Acute Myeloid Leukemia, Core-Binding Factor
Phase 4CompletedShanghai General Hospital, Shanghai Jiao Tong University School of Medicine682017-01-012024-10-01
King's Invasive Aspergillosis Study II
Posaconazole - Aplastic Anemia, Leukemia, Myeloid, Acute
Phase 4CompletedKing's College Hospital NHS Trust1202016-12-072020-04-02
A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
Dasatinib Tablets - Chronic Myelogenous Leukemia - Chronic Phase
Phase 4CompletedChia Tai Tianqing Pharmaceutical Group Co., Ltd.622016-05-102021-06-14
Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.
Nilotinib - Chronic Myeloid Leukemia
Phase 4CompletedNovartis Pharmaceuticals1712016-02-182022-07-22

Showing 20 of 89. Sign in to see all of them.

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (30)  ·  Leukemia, Myeloid, Acute (19)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (16)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (8)  ·  Myelodysplastic Syndromes (7)  ·  Lymphoma (6)  ·  Leukemia, Myeloid, Chronic-Phase (4)  ·  Leukemia, Promyelocytic, Acute (4)  ·  Neoplasm, Residual (4)  ·  Recurrence (4)  ·  Lymphoma, Mantle-Cell (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Neoplasms (3)  ·  Neutropenia (3)

Broader conditions

Hemic and Lymphatic Diseases (89)  ·  Neoplasms by Histologic Type (89)  ·  Hematologic Diseases (87)  ·  Neoplasms (86)  ·  Immune System Diseases (46)  ·  Immunoproliferative Disorders (43)  ·  Lymphatic Diseases (43)  ·  Lymphoproliferative Disorders (43)  ·  Leukemia, Myeloid (41)  ·  Pathological Conditions, Signs and Symptoms (40)  ·  Leukemia, Lymphoid (38)  ·  Pathologic Processes (37)  ·  Disease Attributes (29)  ·  Chronic Disease (27)

Interventions

Cytarabine (20)  ·  Vincristine (15)  ·  Cyclophosphamide (14)  ·  Methotrexate (13)  ·  Dexamethasone (12)  ·  Mercaptopurine (12)  ·  Asparaginase (11)  ·  Daunorubicin (10)  ·  nilotinib (9)  ·  Doxorubicin (8)  ·  Prednisolone (8)  ·  Granulocyte Colony-Stimulating Factor (7)  ·  Idarubicin (7)  ·  Etoposide (6)  ·  Imatinib Mesylate (6)

Sponsors

PETHEMA Foundation (14)  ·  Novartis Pharmaceuticals (13)  ·  Goethe University (5)  ·  Pfizer (3)  ·  Technische Universität Dresden (3)  ·  Johann Wolfgang Goethe University Hospital (2)  ·  Ain Shams University (1)  ·  Astes (1)  ·  AstraZeneca (1)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  Bristol-Myers Squibb (1)  ·  Canadian Immunization Research Network (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Charite University, Berlin, Germany (1)  ·  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)

Countries

Spain (20)  ·  Germany (19)  ·  United States (19)  ·  France (11)  ·  China (9)  ·  Belgium (6)  ·  Sweden (6)  ·  United Kingdom (6)  ·  Canada (5)  ·  Italy (5)  ·  Poland (5)  ·  South Korea (5)  ·  Austria (4)  ·  Finland (4)  ·  Hungary (4)

Top investigators

Dieter Hoelzer, MD,PhD (4)  ·  Sanz Miguel Angel, Dr (4)  ·  Bastida Pilar, Dr (2)  ·  Dieter Hoelzer, MD, PhD (2)  ·  Gerhard Ehninger, MD (2)  ·  Xiaofan Zhu, MD (2)  ·  Alessandra Iurlo, MD (1)  ·  Alexander Ngwube, MD (1)  ·  Ali McMichael, MD (1)  ·  Andreas Hochhaus, Professor, MD (1)  ·  Arnon Nagler, MD (1)

Results publications

PMID 36064577, PMID 19144982, PMID 22442346, PMID 22493293, PMID 23024237, PMID 24923295, PMID 27561722, PMID 28751559, PMID 28945881, PMID 14752084, PMID 15014526, PMID 15158091, PMID 15257960, PMID 17223475, PMID 18056840, PMID 19564304, PMID 19720924, PMID 20220063, PMID 20393132, PMID 20442365, PMID 21148082, PMID 21266057, PMID 21670449, PMID 21775497, PMID 21828124, PMID 21940824, PMID 22197676, PMID 22198540, PMID 22241828, PMID 22290953, PMID 22965967, PMID 23630210, PMID 23733379, PMID 23775972, PMID 24117042, PMID 24752047, PMID 25170123, PMID 25253770, PMID 25359988, PMID 25547501, PMID 25975975, PMID 26001791, PMID 26377300, PMID 26863635, PMID 26993758, PMID 27006491, PMID 27771544, PMID 28235771, PMID 28522574, PMID 28529313

NIH funding

2009 (3), 2015 (1), 2018 (1), 2019 (1), P30CA021765 (1), R01CA078957 (1), R01CA091912 (1), U01CA081445 (1)